Canopy Slaps GW With Patent Suit Over Flagship CBD Drug
Canadian cannabis company Canopy Growth is accusing GW Pharmaceuticals of ripping off its patented CBD extraction technology to make the flagship CBD drug Epidiolex....To view the full article, register now.
Already a subscriber? Click here to view full article